TY  - JOUR
AU  - Quintanal-Villalonga, Álvaro
AU  - Ojeda-Márquez, Laura
AU  - Marrugal, Ángela
AU  - Yagüe, Patricia
AU  - Ponce-Aix, Santiago
AU  - Salinas, Ana
AU  - Carnero, Amancio
AU  - Ferrer, Irene
AU  - Molina-Pinelo, Sonia
AU  - Paz-Ares, Luis
PY  - 2018
DO  - 10.1038/s41598-018-20570-3
UR  - http://hdl.handle.net/10668/12085
T2  - Scientific reports
AB  - The FGFR4-388Arg variant has been related to poor prognosis in several types of cancer, including lung cancer. The mechanism underlying this association has not been addressed in detail in patients with this pathology. Here, we report that this FGFR4...
LA  - en
KW  - Animals
KW  - Antigens, CD
KW  - Cadherins
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cell Line, Tumor
KW  - Disease Progression
KW  - Epithelial-Mesenchymal Transition
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Heterografts
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - Mitogen-Activated Protein Kinases
KW  - Mutation
KW  - Nuclear Proteins
KW  - Prognosis
KW  - Receptor, Fibroblast Growth Factor, Type 4
KW  - STAT3 Transcription Factor
KW  - Snail Family Transcription Factors
KW  - Survival Analysis
KW  - Twist-Related Protein 1
KW  - Vimentin
TI  - The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.
TY  - research article
VL  - 8
ER  -